Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients
Viller Tuxen, Ida, Barlebo Ahlborn, Lise, Mau-Soerensen, Morten, Staal Rohrberg, Kristoffer, Cilius Nielsen, Finn, Oestrup, Olga, Westmose Yde, Christina, Richter Vogelius, Ivan, Lassen, Ulrik
Published in British journal of cancer (16.07.2019)
Published in British journal of cancer (16.07.2019)
Get full text
Journal Article
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
Bertelsen, Birgitte, Tuxen, Ida Viller, Yde, Christina Westmose, Gabrielaite, Migle, Torp, Mathias Husted, Kinalis, Savvas, Oestrup, Olga, Rohrberg, Kristoffer, Spangaard, Iben, Santoni-Rugiu, Eric, Wadt, Karin, Mau-Sorensen, Morten, Lassen, Ulrik, Nielsen, Finn Cilius
Published in Npj genomic medicine (21.06.2019)
Published in Npj genomic medicine (21.06.2019)
Get full text
Journal Article
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors
Ahlborn, Lise Barlebo, Tuxen, Ida Viller, Mouliere, Florent, Kinalis, Savvas, Schmidt, Ane Y, Rohrberg, Kristoffer Staal, Santoni-Rugiu, Eric, Nielsen, Finn Cilius, Lassen, Ulrik, Yde, Christina Westmose, Oestrup, Olga, Mau-Sorensen, Morten
Published in Oncotarget (24.08.2018)
Published in Oncotarget (24.08.2018)
Get full text
Journal Article
Copenhagen Prospective Personalized Oncology (CoPPO)-Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials
Tuxen, Ida Viller, Rohrberg, Kristoffer Staal, Oestrup, Olga, Ahlborn, Lise Barlebo, Schmidt, Ane Yde, Spanggaard, Iben, Hasselby, Jane P, Santoni-Rugiu, Eric, Yde, Christina Westmose, Mau-Sørensen, Morten, Nielsen, Finn Cilius, Lassen, Ulrik
Published in Clinical cancer research (15.02.2019)
Published in Clinical cancer research (15.02.2019)
Get full text
Journal Article
Abstract 5393: BRAF mutant allele fraction in circulating tumor DNA as marker of treatment response in BRAF mutated non malignant melanoma cancers identified in the Copenhagen Prospective Personalized Oncology study
Ahlborn, Lise Barlebo, Tuxen, Ida Viller, Oestrup, Olga, Schmidt, Ane Yde, Håkansson, Cecilia Brunhoff, Nielsen, Finn Celius, Lassen, Ulrik, Yde, Christina Westmose, Mau-Sorensen, Morten
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer
Bjerrum, Andreas, Henriksen, Andreas Frederik, Knoop, Ann Søegaard, Berg, Tobias, Tuxen, Ida Elisabeth Viller, Lassen, Ulrik, Petersen, Tonny Studsgaard
Published in BJC Reports (21.10.2024)
Published in BJC Reports (21.10.2024)
Get full text
Journal Article
Actionable targets in recurrent bile duct and pancreatic cancer in a prospective cohort of patients evaluated by whole exome sequencing and SNP array analysis
Tuxen, Ida Elisabeth Viller, Mau-Soerensen, Morten, Yde, Christina Westmose, Joenson, Lars, Oestrup, Olga, Hasselby, Jane Preuss, Santoni-Rugiu, Eric, Lassen, Ulrik Niels, Nielsen, Finn Cilius
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Copenhagen prospective personalized oncology (CoPPO): Sequencing and array-based pipeline for selection of patients to phase 1 studies
Tuxen, Ida Elisabeth Viller, Santoni-Rugiu, Eric, Joenson, Lars, Vikesaa, Jonas, Mau-Soerensen, Morten, Nielsen, Finn Cilius, Lassen, Ulrik Niels
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article